VAERS Explorer
Back to explore

Report #2891824

Received Apr 6, 2026

Office visit
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
61 yrs
State
CA
Recovered
Unknown
Vaccinated
Mar 23, 2026
Onset
Mar 28, 2026
Days to onset
5
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.1Z0133IM / RA

Symptoms (6)

Injection site cellulitisInjection site erythemaInjection site painInjection site pruritusInjection site rashInjection site swelling

Symptom narrative

Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Additional Details: Per patient, she received Capvaxive on 3/23/26. She experienced redness and swelling at injection site, which improved after a few days. However, on Saturday, the swelling worsened and over the next few days, the rash and swelling progressed further down her arm. She went to see her dermatologist, Dr. (namem withheld), on 3/3/26 who diagnosed her with cellulitis and prescribed her Azithromycin 250mg. , Other Vaccines: VaccineTypeBrand: Heplisav-B; Manufacturer: Dynavax; LotNumber: 947358; Route: Intramuscular; BodySite: Left Arm; Dose: 1; VaxDate: UNKNOWN